New research reveals polymyxin B, a last-resort antibiotic against multidrug-resistant Gram-negative bacteria, kills only metabolically active cells by inducing detrimental outer membrane disruptions. High-resolution imaging shows energy-dependent protrusions and shedding of bacterial surfaces precede cell death, but dormant bacteria evade destruction due to inactive metabolism. This discovery explains treatment failures in dormant infections and suggests strategies to sensitize resistant bacteria.